Abstract
Gastrointestinal bleeding (GIB) accounts for a significant proportion of life-threatening bleeding cases occurring after allogeneic haematopoietic stem cell transplantation (allo-HSCT). However, data on GIB after haploidentical HSCT (haplo-HSCT) are not available. A total of 3180 patients received haplo-HSCT at Peking University People’s Hospital from January 2015 to November 2019, and GIB occurred in 188 of these patients (incidence of 5.9%). Platelet counts <30 × 109/L, viral hepatitis, acute kidney injury (AKI), gastrointestinal disease or bleeding before HSCT and sinusoidal obstruction syndrome (SOS) were determined to be significant risk factors for the occurrence of GIB after haplo-HSCT. Grade III-IV acute graft-versus-host disease (aGVHD), AKI, thrombotic microangiopathy (TMA), disseminated intravascular coagulation (DIC) and gastrointestinal disease or bleeding before HSCT were significantly related to mortality in patients with GIB after haplo-HSCT. The predictive models developed for the occurrence and mortality of GIB performed well in terms of discrimination, and they might assist clinicians with personalised strategies for GIB prevention and treatment in patients after haplo-HSCT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lv M, Chang Y, Huang X. Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation. Front Med. 2019;13:45–56. https://doi.org/10.1007/s11684-017-0595-7
Lv M, Huang XJ. Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go. J Hematol Oncol. 2012;5:10 https://doi.org/10.1186/1756-8722-5-10
Xu LP, Wu DP, Han MZ, Huang H, Liu QF, Liu DH, et al. A review of hematopoietic cell transplantation in China: data and trends during 2008-2016. Bone Marrow Transpl. 2017;52:1512–8. https://doi.org/10.1038/bmt.2017.59
Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X, et al. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study. Blood. 2015;125:3956–62. https://doi.org/10.1182/blood-2015-02-627786
Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X, et al. Haploidentical versus matched-sibling transplant in adults with philadelphia-negative high-risk acute lymphoblastic leukemia: a biologically phase III Randomized Study. Clin Cancer Res. 2016;22:3467–76. https://doi.org/10.1158/1078-0432.CCR-15-2335
Wang Y, Wang HX, Lai YR, Sun ZM, Wu DP, Jiang M, et al. Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant. Leukemia. 2016;30:2055–63. https://doi.org/10.1038/leu.2016.110
Han LJ, Wang Y, Fan ZP, Huang F, Zhou J, Fu YW, et al. Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remission. Br J Haematol. 2017;179:120–30. https://doi.org/10.1111/bjh.14854
Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ, et al. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol. 2017;10:25 https://doi.org/10.1186/s13045-017-0398-y
Atilla E, Atilla PA, Bozdag SC, Demirer T. A review of infectious complications after haploidentical hematopoietic stem cell transplantations. Infection. 2017;45:403–11. https://doi.org/10.1007/s15010-017-1016-1
Reisner Y, Aversa F, Martelli MF. Haploidentical hematopoietic stem cell transplantation: state of art. Bone Marrow Transpl. 2015;50:S1–5. https://doi.org/10.1038/bmt.2015.86
Sun Y, Beohou E, Labopin M, Volin L, Milpied N, Yakoub-Agha I, et al. Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database. Haematological. 2016;101:e352–4. https://doi.org/10.3324/haematol.2015.140509
Bashey A, Zhang X, Jackson K, Brown S, Ridgeway M, Solh M, et al. Comparison of outcomes of hematopoietic cell transplants from T-Replete haploidentical donors using post-transplantation cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 allele-matched unrelated donors and HLA-Identical sibling donors: a multivariable analysis including disease risk index. Biol Blood Marrow Transpl. 2016;22:125–33. https://doi.org/10.1016/j.bbmt.2015.09.002
Pihusch R, Holler E, Muhlbayer D, Gohring P, Stotzer O, Pihusch M, et al. The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation. Bone Marrow Transpl. 2002;30:347–54. https://doi.org/10.1038/sj.bmt.1703640
Nevo S, Enger C, Swan V, Wojno KJ, Fuller AK, Altomonte V, et al. Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival. Transplantation. 1999;67:681.
Yeh S, Liao Y, Hsu C, Chen C, Shen Y, Hsueh C, et al. Gastric bleeding due to graft-versus-host disease: discrepancy between endoscopic and histologic assessment. Am J Clin Pathol. 2004;122:919–25. https://doi.org/10.1309/23DAL9F6P74XWJHL
Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat Rev Dis Primers. 2016;2:16037 https://doi.org/10.1038/nrdp.2016.37
Labrador J, Lopez-Anglada L, Perez-Lopez E, Lozano FS, Lopez-Corral L, Sanchez-Guijo FM, et al. Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients. Haematological. 2013;98:437–43. https://doi.org/10.3324/haematol.2012.069559
Labrador J, Lopez-Corral L, Vazquez L, Sanchez-Guijo F, Guerrero C, Sanchez-Barba M, et al. Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant. Br J Haematol. 2015;169:719–25. https://doi.org/10.1111/bjh.13344
Gerber DE, Segal JB, Levy MY, Kane J, Jones RJ, Streiff MB. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention. Blood. 2008;112:504–10. https://doi.org/10.1182/blood-2007-10-117051
Pihusch R, Salat C, Schmidt E, Gohring P, Pihusch M, Hiller E, et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation. 2002;74:1303–9. https://doi.org/10.1097/00007890-200211150-00018
Nevo S, Swan V, Enger C, Wojno KJ, Bitton R, Shabooti M, et al. Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients. Blood. 1998;91:1469–77.
Kumar S, Dispenzieri A, Lacy MQ, Litzow MR, Gertz MA. High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis. Bone Marrow Transpl. 2001;28:381–5. https://doi.org/10.1038/sj.bmt.1703155
Schwartz JM, Wolford JL, Thornquist MD, Hockenbery DM, Murakami CS, Drennan F, et al. Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987–1997: incidence, causes, and outcome. Am J Gastroenterol. 2001;96:385–93. https://doi.org/10.1016/S0002-9270(00)02342-X
Pihusch M. Bleeding complications after hematopoietic stem cell transplantation. Semin Hematol. 2004;41:93–100. https://doi.org/10.1053/j.seminhematol.2003.11.018
Nevo S, Enger C, Hartley E, Borinsky ME, Swan V, Fuller AK, et al. Acute bleeding and thrombocytopenia after bone marrow transplantation. Bone Marrow Transpl. 2001;27:65–72. https://doi.org/10.1038/sj.bmt.1702717
Yan CH, Xu LP, Wang FR, Chen H, Han W, Wang Y, et al. Causes of mortality after haploidentical hematopoietic stem cell transplantation and the comparison with HLA-identical sibling hematopoietic stem cell transplantation. Bone Marrow Transpl. 2016;51:391–7. https://doi.org/10.1038/bmt.2015.306
Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, et al. EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transpl. 2018;53:1401–15. https://doi.org/10.1038/s41409-018-0204-7
Zuckerman GR, Prakash C, Askin MP, Lewis BS. AGA technical review on the evaluation and management of occult and obscure gastrointestinal bleeding. Gastroenterology. 2000;118:201–21. https://doi.org/10.1016/S0016-5085(00)70430-6
Kaur S, Cooper G, Fakult S, Lazarus HM. Incidence and outcome of overt gastrointestinal bleeding in patients undergoing bone marrow transplantation. Dig Dis Sci. 1996;41:598–603. https://doi.org/10.1007/BF02282348
Ramos GP, Binder M, Hampel P, Braga NM, Sunjaya D, Al BB, et al. Outcomes of endoscopic intervention for overt GI bleeding in severe thrombocytopenia. Gastrointest Endosc. 2018;88:55–61. https://doi.org/10.1016/j.gie.2018.01.028
Nagata N, Sakurai T, Shimbo T, Moriyasu S, Okubo H, Watanabe K, et al. Acute severe gastrointestinal tract bleeding is associated with an increased risk of thromboembolism and death. Clin Gastroenterol H. 2017;15:1882–9. https://doi.org/10.1016/j.cgh.2017.06.028
Kim K, Han BJ, Yang S, Na SY, Park S, Boo S, et al. Risk factors and outcome of acute severe lower gastrointestinal bleeding in Crohn’s disease. Digest Liver Dis. 2012;44:723–8. https://doi.org/10.1016/j.dld.2012.03.010
Deutsch D, Romegoux P, Boustiere C, Sabate JM, Benamouzig R, Albaladejo P. Clinical and endoscopic features of severe acute gastrointestinal bleeding in elderly patients treated with direct oral anticoagulants: a multicentre study. Ther Adv Gastroenterol. 2019;12:321926755 https://doi.org/10.1177/1756284819851677
Aoki T, Nagata N, Shimbo T, Niikura R, Sakurai T, Moriyasu S, et al. Development and validation of a risk scoring system for severe acute lower gastrointestinal bleeding. Clin Gastroenterol H. 2016;14:1562–70. https://doi.org/10.1016/j.cgh.2016.05.042
Strate LL, Saltzman JR, Ookubo R, Mutinga ML, Syngal S. Validation of a clinical prediction rule for severe acute lower intestinal bleeding. Am J Gastroenterol. 2005;100:1821–7. https://doi.org/10.1111/j.1572-0241.2005.41755.x
Strate LL, Orav EJ, Syngal S. Early predictors of severity in acute lower intestinal tract bleeding. Arch Intern Med. 2003;163:838 https://doi.org/10.1001/archinte.163.7.838
Xavier SA, Machado FJ, Magalhães JT, Cotter JB. Acute lower gastrointestinal bleeding: are STRATE andBLEED scores valid in clinical practice? Colorectal Dis. 2018. https://doi.org/10.1111/codi.14529.
Aoki T, Yamada A, Nagata N, Niikura R, Hirata Y, Koike K. External validation of the NOBLADS score, a risk scoring system for severe acute lower gastrointestinal bleeding. Plos One. 2018;13:e196514 https://doi.org/10.1371/journal.pone.0196514
Quach DT, Nguyen NT, Vo UP, Le LT, Vo CH, Ho PT, et al. Development and validation of a scoring system to predict severe acute lower gastrointestinal bleeding in vietnamese. Digest Dis Sci. 2020. https://doi.org/10.1007/s10620-020-06253-y
Lee KK, Shah SM, Moser MA. Risk factors predictive of severe diverticular hemorrhage. Int J Surg. 2011;9:83–5. https://doi.org/10.1016/j.ijsu.2010.09.011
Wang X, Han W, Zhao P, Liu X, Wang J, Wang F, et al. Incidence, risk factors, outcomes, and risk score model of acute pancreatitis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Tr. 2020;26:1171–8. https://doi.org/10.1016/j.bbmt.2019.12.721
Ganna A, Reilly M, de Faire U, Pedersen N, Magnusson P, Ingelsson E. Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease. Am J Epidemiol. 2012;175:715–24. https://doi.org/10.1093/aje/kwr374
Sullivan LM, Massaro JM, D’Agostino RB. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23:1631–60. https://doi.org/10.1002/sim.1742
Yin MY, Ruckel S, Kfoury AG, McKellar SH, Taleb I, Gilbert EM, et al. Novel model to predict gastrointestinal bleeding during left ventricular assist device support. Circ Heart Fail. 2018;11:e5267 https://doi.org/10.1161/CIRCHEARTFAILURE.118.005267
Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood. 1998;92:2303–14.
Jacobsohn DA, Kurland BF, Pidala J, Inamoto Y, Chai X, Palmer JM, et al. Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium. Blood. 2012;120:2545–52. https://doi.org/10.1182/blood-2012-04-424135. 2774
Castilla-Llorente C, Martin PJ, McDonald GB, Storer BE, Appelbaum FR, Deeg HJ, et al. Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation. Bone Marrow Transpl. 2014;49:966–71. https://doi.org/10.1038/bmt.2014.69
Tuncer HH. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol. 2012;18:1851 https://doi.org/10.3748/wjg.v18.i16.1851
Zhang X, Liu X, Wang Q, He Y, Zhu X, Zhang J, et al. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome. Eur J Haematol. 2018;100:171–81. https://doi.org/10.1111/ejh.12996
Bacigalupo A. Haemopoietic stem cell transplants: the impact of haemorrhagic complications. Blood Rev. 2003;17:S6–10. https://doi.org/10.1016/s0268-960x(03)90001-4
Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev. 2015;29:191–204. https://doi.org/10.1016/j.blre.2014.11.001
El-Bietar J, Warren M, Dandoy C, Myers KC, Lane A, Wallace G, et al. Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation. Biol Blood Marrow Tr. 2015;21:1994–2001. https://doi.org/10.1016/j.bbmt.2015.06.016
Ly KN, Xing J, Klevens RM, Jiles RB, Holmberg SD. Causes of death and characteristics of decedents with viral hepatitis, United States, 2010. Clin Infect Dis. 2013;58:40–9. https://doi.org/10.1093/cid/cit642
Mikulska M, Nicolini L, Signori A, Rivoli G, Del BV, Raiola AM, et al. Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. Clin Microbiol Infect. 2014;20:O694–701. https://doi.org/10.1111/1469-0691.12611
Mallet V, van Bommel F, Doerig C, Pischke S, Hermine O, Locasciulli A, et al. Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). Lancet Infect Dis. 2016;16:606–17. https://doi.org/10.1016/S1473-3099(16)00118-3
Rencuzogullari A, Binboga S, Aytac E, Rabets J, Stocchi L, Ozuner G. Incidence, management, and risk factors for lower gastrointestinal bleeding in renal transplant recipients. Transpl P. 2017;49:501–4. https://doi.org/10.1016/j.transproceed.2017.02.001
Fiaccadori E, Maggiore U, Clima B, Melfa L, Rotelli C, Borghetti A. Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure. Kidney Int. 2001;59:1510–9. https://doi.org/10.1046/j.1523-1755.2001.0590041510.x
Aggarwal A, Pant R, Kumar S, Sharma P, Gallagher C, Tatooles AJ, et al. Incidence and Management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg. 2012;93:1534–40. https://doi.org/10.1016/j.athoracsur.2012.02.035
Ji R, Shen H, Pan Y, Wang P, Liu G, Wang Y, et al. Risk score to predict gastrointestinal bleeding after acute ischemic stroke. BMC Gastroenterol. 2014;14:130 https://doi.org/10.1186/1471-230X-14-130
Shalev A, Zahger D, Novack V, Etzion O, Shimony A, Gilutz H, et al. Incidence, predictors and outcome of upper gastrointestinal bleeding in patients with acute coronary syndromes. Int J Cardiol. 2012;157:386–90. https://doi.org/10.1016/j.ijcard.2010.12.081
Wang L, Pei D, Ouyang YQ, Nie X. Meta-analysis of risk and protective factors for gastrointestinal bleeding after percutaneous coronary intervention. Int J Nurs Pract. 2019;25:e12707 https://doi.org/10.1111/ijn.12707
Kelly JP, Kaufman DW, Koff RS, Laszlo A, Wiholm BE, Shapiro S. Alcohol consumption and the risk of major upper gastrointestinal bleeding. Am J Gastroenterol. 1995;90:1058–64.
Kaufman DW, Kelly JP, Wiholm BE, Laszlo A, Sheehan JE, Koff RS, et al. The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption. Am J Gastroenterol. 1999;94:3189–96. https://doi.org/10.1111/j.1572-0241.1999.01517.x
Lauffenburger JC, Rhoney DH, Farley JF, Gehi AK, Fang G. Predictors of gastrointestinal bleeding among patients with atrial fibrillation after initiating dabigatran therapy. Pharmacotherapy. 2015;35:560–8. https://doi.org/10.1002/phar.1597
Moukarbel GV, Signorovitch JE, Pfeffer MA, McMurray JJ, White HD, Maggioni AP, et al. Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial. Eur Heart J. 2009;30:2226–32. https://doi.org/10.1093/eurheartj/ehp256
Nelson AM, Juckett MB, Coe CL, Costanzo ES. Illness perceptions predict health practices and mental health following hematopoietic stem cell transplantation. Psychooncology. 2019;28:1252–60. https://doi.org/10.1002/pon.5075
Acknowledgements
This work was supported by the National Key Research and Development Programme of China (No. 2017YFA0105503, No. 2017YFA0105500), Key Programme of National Natural Science Foundation of China (No. 81730004), National Natural Science Foundation of China (No. 81670116), Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81621001), Beijing Natural Science Foundation (No. 7171013, H2018206423) and Beijing Municipal Science and Technology Commission (No. Z171100001017084).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sun, X., Su, Y., Liu, X. et al. Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models. Bone Marrow Transplant 56, 1341–1351 (2021). https://doi.org/10.1038/s41409-020-01187-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-020-01187-5
This article is cited by
-
Diagnostic prediction of gastrointestinal graft-versus-host disease based on a clinical- CT- signs nomogram model
Insights into Imaging (2024)
-
Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
Bone Marrow Transplantation (2024)
-
Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infection
Bone Marrow Transplantation (2023)